Xinan Wang
@XinAnnWang
Followers
126
Following
2K
Statuses
84
Postdoc Fellow @HarvardChanSPH @DanaFarber #Lungcancer #PrecisionMedicine
Boston, MA
Joined October 2014
Just in time! Come join us with @saorisakaue on 11/19 for her recent work revealing genetic regulatory mechanisms through eQTL causal variants! @HarvardBiostats @HarvardEpi
0
2
13
RT @XihongLin: Join us for the 2024 Harvard PQG conference on "AI for Genomics and Health" in Boston on Oct 17-18, 2024. A fantastic lineu…
0
9
0
Join us with @Aoxing2 next Tuesday at HSPH, and we got a fantastic lineup of speakers! Stay tuned! @HarvardChanSPH @HarvardBiostats @dfcidatascience @HarvardEpi
Hi - I will give a seminar about our recently published Nature paper on “mosaic X chromosome loss” at the PQG working group NEXT TUESDAY! Welcome to Join the talk and discussion in person!! ⏰Time: 1-2 PM, Tuesday, Oct 22 🏠Location: Biostats Conference Room (2-426), Harvard Chan School (Thanks, @Tony_Chen6, for the invitation! Excellent seminars have also been scheduled for Nov 19 by @saorisakaue and Dec 17 by @yk_tani!)
1
1
7
RT @BiagioRicciutMD: Out in @NatureComms our collaborative effort showing how adaptive mechanisms & increased GTP loading confer resistance…
0
14
0
RT @BiagioRicciutMD: Thanks @Annals_Oncology for featuring our review on how to optimize the use of #TMB for predicting #ICI efficacy on th…
0
14
0
RT @DiFedericoMD: Take a look at our comprehensive review on tumor mutational burden (TMB) and its application in clinical practice, led by…
0
8
0
RT @Annals_Oncology: In Annals of Oncology, @BiagioRicciutMD & coll. review challenges & opportunities for TMB & immunotherapy: 🔹Technical…
0
24
0
RT @DanaFarberNews: In a new study published in @JCO_ASCO, @DrMarkAwad, @BiagioRicciutiMD, and @GLambertiMD @DanaFarber have uncovered mech…
0
15
0
RT @BiagioRicciutMD: 🚨Out in @JCO_ASCO our work dissecting the genomic & immunophenotypic correlates of acquired resistance (AR) to PD-(L)1…
0
27
0
0
0
1
RT @jitcancer: New #JITC short report: Multi-institutional analysis of aneuploidy & outcomes to chemoradiation and durvalumab in stage III…
0
4
0
RT @SashaGusevPosts: I'm writing a molecular perspective on heritability, behavior, (and eventually) race/ancestry, group differences. The…
0
51
0
RT @jkpritch: I'm delighted to release the first half of my new open-access online textbook in human population genetics:
0
1K
0
Glad to join BMC Cancer!
Warm welcome to our new #BMCCancer Editorial Board Members @XinAnnWang, @sonampuri, @Nader_Guilherme, @shwetabhsinha23 and @RkouzyMD. We look forward to working with you! Interested in joining #BMCCancer? Visit <gt;.
0
0
11
RT @IASLC: The #WCLC23 Tobacco Control & Smoking Cessation Education Award Winners have been announced. Congratulations! #LCSM
https://t.co…
0
3
0
Fantastic talk by 🌟@BiagioRicciutMD showing Pembro monotherapy continues to demonstrate a meaningful long-term survival benefit in pts w/ advanced NSCLC and a PD-L1 ≥90%. NSCLCs with very high PD-L1 may have a more favorable genomic and immunophenotypic profile. #WCLC23 @IASLC
0
1
8
Thanks @IASLC #WCLC23 for recognizing our work on smoking cessation and OS among pts w/ NSCLC. This is my first WCLC and I am extremely honored to receive the Tobacco Control & Smoking Cessation Early Career Award! @DChristianiMD @HarvardChanERC @HarvardChanSPH @MGH_PCCM
Just finished co-chairing mini oral abstract session on lung cancer prevention, risk reduction and tobacco control with @LungDocDoug. Excellent work in these areas! Congratulations to all presenters! @IASLC #WCLC23 #LCSM @neildwallaceie @XinAnnWang @mahdi_iarc @nathan_harrison
1
2
20
1
0
1
RT @ShaiCarmi: Very nice preprint. The authors predict "personalized" accuracy (unexplained variance) of polygenic scores, using regression…
0
22
0